Pathophysiological aspects of S-100 β protein;Physiopathologie de la protéine S-100 β: Intérêt de son dosage en biologie clinique

Immuno-Analyse et Biologie Specialisee

Volumn 17, Issue 5, 2002, Pages 280-286

  Beaudeux, J L ^a   Soler, C ^b   Foglietti, M J ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Centre d'Imagerie Nucleaire   (France)

Author keywords

Central nervous system; Cerebral disease; Melanoma; S 100 protein

Indexed keywords

BIOLOGICAL MARKER; CALCIUM ION; PROTEIN S100B;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN INJURY; BRAIN ISCHEMIA; CALCIUM BINDING; CALCIUM CELL LEVEL; CELL PROLIFERATION; DISEASE MARKER; EXTRACELLULAR SPACE; GLIA CELL; HUMAN; INTRACELLULAR SPACE; MELANOMA; NERVE CELL; NERVE FIBER GROWTH; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; STROKE;

EID: 1042266396     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2532(02)01210-3     Document Type: Review

References (35)

1. Allore R.J., Friend W.C., O'Hanlon D., Neilson K.M., Baumal R., Dunn R.J., Marks A. Cloning and expression of the human S100 ß gene. J Biol Chem. 265:1990;15537-15543.
2. Augusseau-Caillot A., Soler C., Teyssier F., Perrot J.L., Tiffet O., Cambazard F., Cuilleret J., Dumollard J.M. Interest of PS100 assay when (99m)Tc sestamibi scintigraphy failed to identify lymph node metastases of melanoma. Eur J Dermatol. 11:2001;432-435.
3. Aurell A., Rosengren L.E., Karlsson B., Olsson J.E., Zbornikova V., Haglid K.G. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke. 22:1991;1254-1258.
4. Beaudeux J.L., Léger P., Dequen L., Gandjbakhch I., Coriat P., Foglietti M.J. Influence of Hemolysis ont the Measurement of S-100 ß Protein and neuron-specific Enolase Plasma Concentrations during Coronary Artery Bypass Grafting. Clin Chem. 46:2000;989-990.
5. Buttner T., Weyers S., Postert T., Sprengelmeyer R., Kuhn W. S-100 protein:serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke. 28:1997;1961-1965.
6. Dequen L., Beaudeux J.L., Leger P., Gandjbakhch I., Coriat P., Foglietti M.J. Cinétique d'évolution plasmatique de la protéine S-100 β au cours de pontages aortocoronariens utilisant différentes techniques opératoires. Immunoanal Bio Spec. 14:1999;119-124.
7. Donato R. S100:a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 33:2001;637-668.
8. Duncan A.M.V., Higgins J., Dunn R.J., Allore R., Marks A. A refined sublocalization of the human gene encoding the ß subunit of S100 protein (S100 ß) and confirmation of a subtle t (9:21) translocation using in situ hybridization. Cytogenet Cell Genet. 50:1989;234-235.
9. Fagnart O.C., Sindic C.J.M., Laterne C. Particle counting immunoassay of S-100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem. 34:1988;1387-1391.
10. Gazzolo D., Vinesi P., Concetta Geloso M., Marcelletti C., Lorio F.S., Cipriani A., Marianeschi S.M., Michetti F. S100 blood concentrations in children subjected to cardiopulmonary bypass. Clin Chem. 44:1998;1058-1060.
11. Ghandour M.S., Langley O.K., Labourdette G., Vincendon G., Gombos G. Specific and artefactual cellular localization of S-100 protein: an astrocyte marker in rat cerebellum. Dev Neurosci. 4:1981;66-78.
12. Harris D.N., Bailey S.M., Smith P.L., Taylor K.M., Oatridge A., Bydder G.M. Brain swelling in first hour after coronary artery bypass surgery. Lancet. 342:1993;586-587.
13. Henze G., Dummer R., Joller-Jemelka H.I., Boni R., Burg K. Serum S-00 - A marker for disease monitoring in metastatic melanoma. Dermatology. 194:1997;208-212.
14. Hilt D.C., Kligman D. The S-100 protein family:a biochemical and functional overview. Novel Calcium-Binding Proteins. Fundamentals and Clinical Implications. 1991;65-103.
15. Ingebrigtsen T.I., Romner B. Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury. J Neurosurg. 85:1996;945-948.
16. Ingebrigtsen T., Romner B., Trumpy J.H. Management of minor head injury: the value of early computed tomography and serum protein S-100 measurements. J Clin Neurosci. 4:1997;29-33.
17. Iwasaki Y., Shiojima T., Kinoshita M. S100 beta prevents the death of motor neurons in newborn rats after sciatic nerve section. J Neurol Sci. 151:1997;7-12.
18. Johnsson P., Lundqvist C., Lindgren A., Ferencz I., Alling C., Stahl E. Cerebral complications after cardiac surgery assessed by S-100 and NSE levels in blood. J Cardiothorac Vasc Anesth. 9:1995;694-699.
19. Kimura S., Kato K., Semba R., Isobe T. Regional distribution of S-100a0 (αα), S-100a (αß) and S-100b (ßß) in the bovine central nervous tissue determined with a sensitive enzyme immunoassay system. Neurochem Int. 6:1984;513-518.
20. Kligman D., Hilt D.C. The S100 protein family. Trends Biochem Sci. 13:1988;437-443.
21. Kligman D., Marshak D.R. Isolation and characterisation of a neurite extension factor from bovine brain. Proc Natl Acad Sci USA. 82:1985;437-443.
22. Landry C.F., Ivy G.O., Dunn R.J., Marks A., Brown I.R. Expression of the gene encoding the ß-subunit of S-100 protein in the developing rat brain analysed by in situ hybridization. Mol Brain Res. 6:1989;251-262.
23. Missler U., Wiesmann M., Friedrich C., Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 28:1997;1956-1960.
24. Nakajima T., Watanabe S., Sato Y., Kameya T., Shinosuto Y., Ishihara K. Immunohistochemical demonstration of S-100 protein in malignant melanoma and pigmented naevus, and its diagnostic application. Cancer. 50:1982;912-918.
25. Otto M., Wiltfang J., Schultz E., Zerr I., Otto A., Pfahlberg A., Gefeller O., Uhr M., Giese A., Weber T., Kretzschmar H.A., Poser S. Diagnosis of Creutzfeld-Jakob disease by measurement of S100 protein in serum: prospective case-control study. BMJ. 316:1998;577-582.
26. Otto M., Stein H., Szudra A., Zerr I., Bodemer M., Geffeler O., Poser S., Kretzschmar H.A., Mader M., Weber T. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeld-Jakob disease. J Neurol. 244:1997;566-570.
27. Persson L., Hardemark H.G., Gustafsson J., Rundstrom G., Mendel-Hartwig I., Esscher T., Pahlman S. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum:markers of cell damage in human central nervous system. Stroke. 18:1987;911-918.
28. Rustandi R.R., Drohat A.C., Baldisseri D.M., Wilder P.T., Weber D.J. The Ca (2+) - dependent interaction of S100B (beta beta) with a peptide derived from p53. Biochemistry. 37:1998;1951-1960.
29. Semba R., Kato K., Isobe T., Kashiwamata S. Purification of S-100a0 protein from rat kidney. Brain Res. 401:1987;9-13.
30. Sheng J.C., Mrak R.E., Griffin W.S. S100 beta protein expression in Alzheimer disease: potential role in the pathogenis of neuritic plaques. J Neurosci Res. 39:1994;398-404.
31. Van Eldik L.J., Griffin W.S. S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim Biophys Acta. 1223:1994;348-403.
32. Von Schoultz E., Hansson O., Djureen E., Hansson J., Karnell R., Nilsson B., Stigbrand T., Ringborg U. Pronostic value of serum analyses of S-100 protein in malignant melanoma. Melanoma Res. 6:1996;133-137.
33. Wiesmann M., Missler U., Gottmann D., Gehring S. Plasma S-100b concentration in healthy adults is age and sex independent. Clin chem. 44:1998;1056-1058.
34. Zimmer D.B., Cornwall E.H., Landar A., Song W. The S100 protein family: history, function, and expression. Brain Res Bull. 37:1995;417-429.
35. Zimmer D.B., Song W., Zimmer W.E. Isolation of a rat S100α cDNA and distribution of its mRNA in rat tissues. Brain Res Bull. 27:1991;157-162.